Attila Fejer – General Manager, Eli Lilly Romania
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the pharmaceutical industry in the country. He shares the…
Address: Bucharest Business Park (BBP), Str. Menuetului nr. 12, corp D, Et.2, sector 1, cod 013681, Bucuresti, Romania
Tel: 021.402.30.00
Web: http://www.lilly.com/Pages/home.aspx
Eli Lilly Worldwide
• Headquarters located at Indianapolis, Indiana, U.S.A.
• Approximately 40 thousand employees worldwide
• Approximately 8 thousand employees engaged in research and development
• Clinical research conducted in more than 50 countries
• Research and development facilities located in 8 countries
• Manufacturing plants located in 13 countries
• Products marketed in 143 countries
• Net Sales of US $ 21.8 billions for 2009
• R&D expenditure: approx 20% of Sales
Eli Lilly began operations in Romania in the 1990s.
Worldwide, Lilly´s medicines are currently treating schizophrenia, diabetes, bipolar disorder, stress urinary incontinence, erectile dysfunction, depression, cancer, heart disease, pain, infections and gastric disorders and bringing relief to millions of people.
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the pharmaceutical industry in the country. He shares the…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on…
The country manager of a leading specialty care bio-business reveals how the economic and geo-social fundamentals in Romania are highly attractive from an innovative pharmaceutical producer standpoint. He speaks about…
The longstanding GM of one of the foremost data management services companies for Romanian healthcare analyses some of the key trends sweeping the industry while at he same time outlining…
The founder of the group explains how the pharmacy chain has become a regional trailblazer by redefining the concept of ‘neighborhood pharmacy’ along the principles of being cheap, near and…
The association’s longtime executive director outlines the opportunities and challenges for generics companies in the Romanian market. Analyzing in depth the local market regulatory landscape, he proposes modifications to the…
One of the new generation of pharmaceutical general managers in Romania discusses the complexities of introducing innovative therapies on the market and explains how the country has become the ‘to-go-to’…
One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has managed to shape in-county developments in…
The GM of one of the leading generics companies on the Romanian market shares insights into why generics penetration remains underdeveloped and the importance of having an export strategy and…
The president of the association representing clinical research organisations speaks out about Romania’s attractiveness as a destination country in an era of clinical research globalisation. He further sheds ideas on…
Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over these five decades, thorough…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones…
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract foreign investors. In sum,…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market environment was at that…
See our Cookie Privacy Policy Here